UBS AM’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.73M | Sell |
|
|||||
|
2025
Q2 | $3.2M | Buy |
|
|||||
|
2025
Q1 | $2.39M | Sell |
|
|||||
|
2024
Q4 | $6.92M | Sell |
|
|||||
|
2024
Q3 | $8.86M | Sell |
|
|||||
|
2024
Q2 | $8.46M | Buy |
|
|||||
|
2024
Q1 | $6.66M | Sell |
|
|||||
|
2023
Q4 | $8.74M | Buy |
|
|||||
|
2023
Q3 | $3.18M | Buy |
|
|||||
|
2023
Q2 | $802K | Hold |
|
|||||
|
2023
Q1 | $802K | Buy |
|
|||||
|
2022
Q4 | $777K | Buy |
|
|||||
|
2022
Q3 | $208K | Sell |
|
|||||
|
2022
Q2 | $203K | Hold |
|
|||||
|
2022
Q1 | $286K | Hold |
|
|||||
|
2021
Q4 | $443K | Hold |
|
|||||
|
2021
Q3 | $451K | Sell |
|
|||||
|
2021
Q2 | $636K | Buy |
|
|||||
|
2021
Q1 | $698K | Sell |
|
|||||
|
2020
Q4 | $2.06M | Buy |
|
|||||
|
2020
Q3 | $704K | Buy |
|
|||||
|
2020
Q2 | $217K | Buy |
|